Dbv technologies to participate in upcoming eaaci congress 2023

Montrouge, france, june 8, 2023 dbv technologies to participate i n upcoming eaaci congress 2023 dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced upcoming participation in the european academy of allergy and clinical immunology (eaaci) congress, june 9 – 11, 2023, in hamburg, germany. dbv will present three posters and will also host a symposium and exhibit booth in the eaaci exhibit hall.
DBVT Ratings Summary
DBVT Quant Ranking